jayc
2021-11-27

$Novavax(NVAX)$I reviewed all GMP and cGMP certificates for the Novavax's global sites. I can fully understand why Novavax leveraged the manufacturing partnership with Serum. This strategy really makes their CMC package harmonized and simplified as Serum's MHRA GMP certificate covers full line-up of the manufacturing operations from DS/DP to QC Testing without requiring any combinations of sites.

Serum's MHRA GMP Coverage

1. Manufacturing Operations

2. 1.1 Sterile Products

3. 1.3 Biological medical products

4. 1.4 Other products or manufacturing activity

5. 1.5 Packaging

6. 1.5.1 Primary packaging

7. 1.5.2 Secondary packaging

8. 1.6 Quality control testing If Novavax uses other global sites, they need to combine several sites to manufacture Nuvaxovid from DS to DP (fill & finish). This makes their CMC package complicate to keep consistency each for the regulatory agencies and difficult to get approval quickly. No other single site can cover full line-up of the manufacturing operations except Serum.

Novavax made the best choice to get their CMC package optimized. Fantastic strategy !!!! 

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

举报

评论（371）

  • 推荐
  • 最新
  • FabianGracie
    ·2021-11-27
    Interesting, but I don't believe this kind of company is going to make huge progress. There are no "packaged" companies that can grow today. it's new energy and meta.
    回复
    举报
  • JackPowell
    ·2021-11-27
    I know very little about these companies. Do u have any other recommendations? I prefer to buy a portfolio by sector to spread the risk.
    回复
    举报
  • Jabby
    ·2021-11-28
    Good coverage! Pls like!
    回复
    举报
  • BartonBecky
    ·2021-11-27
    COVID-19 is veryyyy bad. I like to invest in pharmaceutical companies that are specific to this virus. I think they have a lot of room for improvement.
    回复
    举报
  • AgathaHume
    ·2021-11-27
    Seems to be a good investment choice, once their technology can break through, it will affect their business. very welll
    回复
    举报
  • Tracccy
    ·2021-11-27
    Their technology seems to have a big market, but it doesn't look like it's going to take a lot of market share. so it's not mine.
    回复
    举报
  • 锐哥来了
    ·2021-11-29
    没看太懂？
    回复
    举报
  • 清清棋坛
    ·2021-11-28
    不错的分享
    回复
    举报
  • BlancheElsie
    ·2021-11-27
    hhh I wish you could be more specific.
    回复
    举报
  • LesleyNewman
    ·2021-11-27
    Thanks for sharing, I'm looking for some data. You gave me some direction.
    回复
    举报
  • BonnieHoyle
    ·2021-11-27
    Pharmaceutical companies are good for invest. So I will buy some stock of them.
    回复
    举报
  • yansuji
    ·2021-11-27
    I like your strategy and agree with u. It's a good choice. that will go up soon.
    回复
    举报
  • 赌命场
    ·2022-02-03
    以色列全國人民接種？不怕未知后果及潛在風險？？？
    回复
    举报
  • Prosper gal
    ·2021-11-29
    Good info
    回复
    举报
  • Lollollol
    ·2021-12-02
    👍
    回复
    举报
  • 梓坚
    ·2021-12-02
    👍👍👍
    回复
    举报
  • 为了生活奔波
    ·2021-11-29
    已阅
    回复
    举报
  • 开心玩股票
    ·2021-11-28
    [Grin]
    回复
    举报
  • eddyglobal1
    ·2021-11-28
    😁😁😁😁😁😁😁
    回复
    举报
  • eddyglobal1
    ·2021-11-28
    really...
    回复
    举报